Manfred Schmolz, PhD

Manfred Schmolz, the founder of the company is the CEO, as well as the CSO of HOT Screen GmbH. More than 25 years ago he pioneered the development of Human Organo-Typic (“HOT”) Co-Culture systems for immunopharmacological research & development. He also invented the TruCulture® system, the only human, organo-typical bed-side test for functional characterization of drug effects in clinical trials.

Prior to his career in contract research he established and headed a drug screening lab prospecting for immunobiological activities in natural sources.

After finishing his studies in microbiology, pharmacology, parasitology and human physiology 1981, Manfred Schmolz worked at the Immunopathology Lab of the University of Tübingen as a doctoral student and as a post-doc (until 1989) in the field of autoimmune disorders, mainly autoaggressive liver diseases.